Mesoblast Company

Mesoblast is a medicine company that develops biologic products for the broad field of regenerative medicine.
Technology: Stem cell therapy, diagnostics
Industry: Public, Regenerative Medicine
Headquarters: Melbourne, Victoria, Australia
Zip: 51-100
Founded Date: 2004-01-01
Employees Number: 51-100
Funding Status: IPO
Acquisitions Number: 3
Investors Number: 3
Total Funding: 412295275
Estimated Revenue: $10M to $50M
Last Funding Date: 2021-03-02
Last Funding Type: Post-IPO Equity

Visit Website
Register and Claim Ownership